Clinical trial
Advancing Safe, Comprehensive, Digitally-Enabled Cancer Pain managemeNT (ASCENT) - Main Trial
NCT06198010 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Advancing Safe, Comprehensive, Digitally-Enabled Cancer Pain managemeNT (ASCENT) - Main Trial
- Lead sponsor
- Mayo Clinic
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 7, 2024
- Completion date
- March 12, 2027
- Enrollment
- 680 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hematopoietic and lymphatic system neoplasm, hematopoietic and lymphoid system neoplasm, malignant solid neoplasm